ULURU

 
home
about us
products
research and development
news

Press Releases
  - 2014
  - 2013
  - 2012
  - 2011
  - 2010
  - 2009
  - 2008
  - 2007
  - 2006
  - 2005

Streaming Audio
  - 2014
  - 2013
  - 2012
  - 2011
  - 2010
  - 2009
  - 2008
  - 2007

contact us
 

home

news

press releases

2005
news

 
  2005 Press Releases  
     
  12/06/05: ULURU Grants Discus Dental Sole U.S. Distribution Rights for Aphthasol, the FDA Approved Prescription Drug for Aphthous Ulcers; Discus Dental to Promote to Consumers and Dental Professionals. (Click here to read more)  
     
  11/22/05: Zindaclin Licensing Collaborations Extended to Include Italy and Spain. (Click here to read more)  
     
 

11/16/05: ULURU Receives First U.S. Army SBIR Funding; Partnered with University of Texas Southwestern Medical Center to Develop Nanoparticle Aggregate Technology.  (Click here to read more)

 
     
 

10/28/05: ULURU Formed to Develop Innovative Oral and Topical Products; Commercialization Strategy Focused on Wound Management, Burn Care and Products for Facial Restoration. (Click here to read more)

 
     
 

10/12/05: ULURU Inc. purchases topical assets of Access  Pharmaceuticals Inc. (Click here to read more)

 
     
     
     

 

 

© 2014 ULURU Inc.

Latest News
ULURU Inc. developed and commercializes Altrazeal®, a transforming powder dressing with proprietary Nanoflex® technology, for the management of exuding wounds.
Visit
www.altrazeal.com
for clinical case studies, patient testimonials, application guidelines, and much more…